Current studentsExisting staffContact us
 

Myeloid neoplasms arising after methotrexate therapy for autoimmune rheumatological diseases do not exhibit poor-risk molecular features

Simple item page
dc.contributor.authorWechalekar, M.D.
dc.contributor.authorZhao, L.-P.
dc.contributor.authorKutyna, M.M.
dc.contributor.authorHong, L.E.
dc.contributor.authorLi, J.
dc.contributor.authorHung, K.
dc.contributor.authorScott, H.S.
dc.contributor.authorBrown, A.
dc.contributor.authorHahn, C.C.
dc.contributor.authorKassahn, K.
dc.contributor.authorLadon, D.
dc.contributor.authorYeung, D.T.
dc.contributor.authorThomas, D.
dc.contributor.authorPatnaik, M.
dc.contributor.authorProudman, S.
dc.contributor.authorAdes, L.
dc.contributor.authorShah, M.V.
dc.contributor.authorKok, C.H.
dc.contributor.authorHiwase, D.K.
dc.date.issued2024
dc.descriptionCorrespondence Data source: Supplementary materials, https://doi.org/10.1038/s41408-024-01093-9
dc.description.statementofresponsibilityMihir D. Wechalekar, Lin-Pierre Zhao, Monika M. Kutyna, Lih En Hong, Joule Li, Kevin Hung, Hamish S. Scott, Anna Brown, Christopher C. Hahn, Karin Kassahn, Dariusz Ladon, David T. Yeung, Daniel Thomas, Mrinal Patnaik, Susanna Proudman, Lionel Ades, Mithun V. Shah, Chung H. Kok, and Devendra K. Hiwase
dc.identifier.citationBlood Cancer Journal, 2024; 14(1):116-1-116-5
dc.identifier.doi10.1038/s41408-024-01093-9
dc.identifier.issn2044-5385
dc.identifier.issn2044-5385
dc.identifier.orcidKutyna, M.M. [0000-0003-2315-091X]
dc.identifier.orcidHong, L.E. [0000-0003-1964-4087]
dc.identifier.orcidScott, H.S. [0000-0002-5813-631X]
dc.identifier.orcidBrown, A. [0000-0002-9023-0138]
dc.identifier.orcidHahn, C.C. [0000-0001-5105-2554]
dc.identifier.orcidKassahn, K. [0000-0002-1662-3355]
dc.identifier.orcidYeung, D.T. [0000-0002-7558-9927]
dc.identifier.orcidProudman, S. [0000-0002-3046-9884]
dc.identifier.orcidKok, C.H. [0000-0002-3181-7852]
dc.identifier.orcidHiwase, D.K. [0000-0002-6666-3056]
dc.identifier.urihttps://hdl.handle.net/2440/143864
dc.language.isoen
dc.publisherNature Publishing Group
dc.relation.granthttp://purl.org/au-research/grants/nhmrc/1195517
dc.rights© Crown 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http:// creativecommons.org/licenses/by/4.0/.
dc.source.urihttps://doi.org/10.1038/s41408-024-01093-9
dc.subjectRheumatic Diseases; Autoimmune Diseases
dc.subject.meshHumans
dc.subject.meshRheumatic Diseases
dc.subject.meshAutoimmune Diseases
dc.subject.meshMethotrexate
dc.subject.meshAntirheumatic Agents
dc.subject.meshAdult
dc.subject.meshAged
dc.subject.meshMiddle Aged
dc.subject.meshFemale
dc.subject.meshMale
dc.titleMyeloid neoplasms arising after methotrexate therapy for autoimmune rheumatological diseases do not exhibit poor-risk molecular features
dc.typeJournal article
pubs.publication-statusPublished

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
hdl_143864.pdf
Size:
1.79 MB
Format:
Adobe Portable Document Format
Description:
Published version
Download

Collections

Research Outputs